Study on Drug Resistance of Escherichia coli Isolated from Chicken and Swine in Organic Farm

To determine the drug resistance of E.coli strains from swine and chicken in organic farm,collection of stool specimens was conducted in one organic farm in Conghua city,Guangdong province in 2014,in which 118 E.coli strains were separated,including 55 from chicken and 63 from swine.The sensitivity of the E.coli strains from swine and chicken to 18 kinds of drugs was detected through agar dilution method.Similar properties in drug resistance were observed both in E.coli strains from swine and chicken in the same organic farm.In consideration of the resistance rate,samples were relatively sensitive to ceftazidime,cefquinome,cefoxitin,amikacin,apramycin,gentamicin,neomycin,florfenicol,chloramphenicol,imipenem,ciprofloxacin and olaquindox (chicken 0 to 21.8%;swine 0 to 14.3%).These isolates showed moderate resistance to ampicillin and streptomycin (chicken 29.1% to 38.2%;swine 23.8% to 27.0%).About 56.4% chicken isolates and 47.6% swine isolates showed resistant to more than 3 kinds of drugs.However,severe resistance was observed in trimethoprim-sulphamethoxazole,tetracyclineand and doxycycline (chicken 45.5%,76.4% and 72.7%;swine 50.8%,81.0% and 68.3%).The results also indicated that under organic farming mode,the drug resistance rates of E.coli strains from swine and chicken were relatively low in general.Multi-drug resistance existed but was relatively slight.Although the drug resistance rate to several specific antimicrobials was high,it was still lower than that in conventional farms.Since most studies focused on the drug resistance of the bacteria under conventional farming model,this study filled the blank of the research of drug resistance under organic farming model.     

牛源无乳链球菌耐药性与毒力基因的表达量差异分析

【目的】 研究无乳链球菌对抗菌药物的耐药性,分析无乳链球菌毒力基因与耐药基因的携带情况。【方法】 分别采用微量肉汤稀释法和普通PCR的方法,检测牛源无乳链球菌对16种抗菌药物的耐药性和相关耐药基因及毒力基因,并且采用荧光定量PCR技术对不同菌株的8种毒力基因的表达量差异进行分析。【结果】 （1）无乳链球菌对11种药物的敏感性达到了65%以上,其中敏感性最高的是氟苯尼考（92.4.%）和头孢噻呋（88.4%）,对氨苄西林、红霉素、克林霉素的耐药率均达到了50%以上,对磺胺异恶唑的耐药率也达到了45%以上。（2）无乳链球菌耐药基因gyrA、sul1、ermB、ermC的检出率分别为100%、 86.67%、 93.3%、 33.3%,而ermA、sul2、sul3及parC 4种耐药基因未检出。（3）无乳链球菌毒力基因pavA、cfb、fbsA、bibA、cspA、sip、iagA、hylB的检出率为100%,rib检出率为13.3%,bca的检出率为53.3%,cyl E检出率为73.3%;未检测到bac、lmb、scp B这三种毒力基因。（4）不同菌株之间毒力基因的表达量有显著性差异（P<0.05）。【结论】 无乳链球菌对红霉素和克林霉素的耐药率较高,无乳链球菌毒力因子是宿主感染疾病的重要因素。     

不同地理种群棉蚜三种关键性酶活差异及其与抗性相关性

【目的】研究新疆不同地理种群棉蚜3种酶的活性及抗药性的差异。【方法】测定新疆库尔勒、五家渠、石河子、奎屯、哈密地区棉蚜和实验室敏感种群羧酸酯酶、谷胱甘肽-S-转移酶、乙酰胆碱酯酶活性,并分析3种酶活性与吡虫啉抗性之间的关系。【结果】库尔勒、五家渠、石河子、奎屯和哈密地区乙酰胆碱酯酶和谷胱甘肽-S-转移酶的比活力比值分别为4.2、2.7、2.3、2.5、2.1倍和2.3、1.5、1.3、2.5、2.1倍,差异显著（P<0.05）;羧酸酯酶比活力比值为6.5、4.2、3.4、2.7、1.2倍,除哈密地区相对接近外,其余地区均明显高于1.0,差异显著（P<0.05）,2种棉蚜关键解毒酶和1种神经传导关键性酶与抗药性之间存在一定相关性。【结论】各地理种群棉蚜3种酶活性均显著高于敏感种群（P<0.05）,且彼此之间存在差异性,羧酸酯酶在棉蚜感受到吡虫啉杀虫剂胁迫时极有可能起到重要作用。     

拟无枝酸菌宿主构建及次级代谢基因簇异源表达

为将生长快、发酵时间短、遗传操作便捷的稀有放线菌拟无枝酸菌TNS106开发成异源表达宿主,通过同源重组将内源的瑞斯托霉素生物合成关键基因rpsA替换为ΦC31和ΦBT1噬菌体细菌附着位点attB,清除代谢背景并引入整合位点,得到菌株HXR1;将含有来自天蓝色链霉菌的放线紫红素基因簇或来自刺糖多孢菌的多杀菌素基因簇的质粒转到HXR1进行异源表达,检测发酵产物。结果显示,HXR1成功表达放线紫红素和多杀菌素;与红色糖多孢菌宿主LJ161相比,放线紫红素的产生提前1 d,产量提高1.3倍。拟无枝酸菌异源表达宿主HXR1可为从链霉菌和稀有放线菌中发现新的次级代谢产物提供有用的平台。     

乳源蜡样芽胞杆菌耐药性、毒力因子检测及分子特征研究

为了解乳品来源蜡样芽胞杆菌携带的毒力因子、分子特征及耐药性,对2016—2019年分离自乳品的122株蜡样芽胞杆菌,采用纸片扩散法（K-B纸片法）测定了分离株对氯霉素、庆大霉素等9种抗生素的耐药性,使用聚合酶链式反应法检测了菌株携带的毒力因子,同时采用脉冲场凝胶电泳（pulsed field gel electrophoresis,PFGE）检测分离株的分子特征。结果表明,122株蜡样芽胞杆菌均对氯霉素、庆大霉素、阿米卡星敏感;对红霉素、克林霉素和环丙沙星的中介率分别为5.74%、4.92%和0.82%, 9.84%的菌株对复方新诺明具有耐药性,8.20%的菌株对四环素具有耐药性,4.10%的菌株对利福平具有耐药性。122株蜡样芽孢杆菌都检出了蜡样芽孢杆菌的非溶血型肠毒素基因nheA、nheB及肠毒素FM基因entFM;nheC、bceT、cytK、hblA、hblC、hblD、ces和EM1基因的检出率分别为99.18%、37.70%、31.15%、29.51%、24.59%、8.20%、、6.56%和6.56%。122株蜡样芽胞杆菌被分成15簇,未见明显的优势带型。由此可见,2016—2019年收集的蜡样芽胞杆菌乳品分离株携带多种毒力基因,约10%的菌株对复方新诺明、四环素、利福平等具有耐药性,PFGE呈现多种带型,为蜡样芽孢杆菌引起的食源性疾病的预警、预防和治疗提供参考。     

控制对虾弧菌病药物的实验研究

研究了一株对虾弧菌病病原菌对２４种药物的敏感性，测定了几种抗菌性较强、抗菌谱较广且价格较低廉的药物对该菌的最低抑菌浓度（ＭＩＣ）和最低杀菌浓度（ＭＢＣ）以及药物在海水环境中对该菌作用的有效性和药物联用效果。结果表明，不同药物具有不同的ＭＩＣ值，在特定的实验条件下，药物之间的作用表现为：协同、拮抗和无关三种结果，不同药物在不海水中作用时间不一。本文对药物滥施乱用的后果进行了讨论并提出了效控制病菌、合     

大头鲤粘孢子虫病的治疗试验

对患粘孢子虫病的大头鲤分别用食盐、亚甲基蓝、硝酸亚汞、敌百虫、硫酸亚铁和孔雀石绿几种药物进行治疗。结果表明 ,敌百虫与硫酸亚铁合剂以 1mg·L- 1 :0 2mg·L- 1 溶液治疗效果最好 ,治愈率 80 % ;1mg·L- 1 敌百虫溶液的效果次之 ,治愈率 5 0 % ;用0 1mg·L- 1 硝酸亚汞溶液的治愈率为 1 0 % ;用食盐溶液、亚甲基蓝溶液与孔雀石绿溶液处理无明显治疗效果。     

Oral Cyclosporine Treatment in Dogs: A Review of the Literature

Cyclosporine is an immunomodulatory drug used to treat an increasing spectrum of diseases in dogs. Cyclosporine is a calcineurin inhibitor, ultimately exerting its inhibitory effects on T‐lymphocytes by decreasing production of cytokines, such as interleukin‐2. Although, in the United States, oral cyclosporine is approved in dogs only for treatment of atopic dermatitis, there are many other indications for its use. Cyclosporine is available in 2 oral formulations: the original oil‐based formulation and the more commonly used ultramicronized emulsion that facilitates oral absorption. Ultramicronized cyclosporine is available as an approved animal product, and human proprietary and generic preparations are also available. Bioavailability of the different formulations in dogs is likely to vary among the preparations. Cyclosporine is associated with a large number of drug interactions that can also influence blood cyclosporine concentrations. Therapeutic drug monitoring (TDM) can be used to assist in attaining consistent plasma cyclosporine concentrations despite the effects of varying bioavailability and drug interactions. TDM can facilitate therapeutic success by guiding dose adjustments on an individualized basis, and is recommended in cases that do not respond to initial oral dosing, or during treatment of severe, life‐threatening diseases for which a trial‐and‐error approach to dose adjustment is too risky. Pharmacodynamic assays that evaluate individual patient immune responses to cyclosporine can be used to augment information provided by TDM.     

兽药残留检测技术应用现状及发展方向

概述了畜禽产品中兽药残留的“快速筛查方法”和“确证检测方法”,分别介绍了各种检测方法的特点和应用现状,并对兽药残留检测技术在未来的研究方向进行了展望,为研究更高效的检测方法提供参考,进而推动畜禽产品质量安全监管工作,保障畜禽产品质量安全。